Am. J. Respir. Crit. Care Med., Vol 153, No. 6, Jun 1996, 1875-1879.
N-acetylcysteine inhibits loss of diaphragm function in streptozotocin- treated rats
W Hida, C Shindoh, J Satoh, M Sagara, Y Kikuchi, T Toyota and K Shirato
First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
We examined whether streptozotocin (STZ)-induced diabetic rats have an
impairment in diaphragm contractility, and if so, whether N- acetylcysteine
(NAC), a nonspecific antioxidant, prevents this impairment. First,
diaphragm contractility, assessed by tension- frequency relationships and
twitch kinetics in in vitro diaphragm strip preparations of Wistar rats,
was obtained on Days 3 and 7 after administration of STZ of 30 or 60 mg/kg
body weight, and compared with that of the control group. Second, NAC at
500 mg/kg body weight or vehicle solution was administered orally every day
in rats treated with STZ at 60 mg/kg body weight, and diaphragm function on
Day 7 after starting NAC treatment was compared between vehicle control and
STZ- treated groups. We found that diaphragm function in STZ-treated rats,
which had hyperglycemia, decreased in a dose- and time-dependent manner.
NAC inhibited the decrease in diaphragm contractility in STZ- treated rats
without reducing blood glucose. These findings suggest that the loss of
diaphragm function in STZ-induced diabetic rats is not directly related to
hyperglycemia. The data are consistent with secondary alterations of normal
cytokine signaling or changes in the redox state of the cell, both of which
could be affected by NAC treatment.
This article has been cited by other articles:

|
 |

|
 |
 
E. van Lunteren and M. Moyer
Oxidoreductase, morphogenesis, extracellular matrix, and calcium ion-binding gene expression in streptozotocin-induced diabetic rat heart
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E759 - E768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Barreiro, J. B. Galdiz, M. Marinan, F. J. Alvarez, S. N. A. Hussain, J. Gea, and on behalf of the ENIGMA in COPD project
Respiratory loading intensity and diaphragm oxidative stress: N-acetyl-cysteine effects
J Appl Physiol,
February 1, 2006;
100(2):
555 - 563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Barreiro, D. Sanchez, J. B. Galdiz, S. N. A. Hussain, J. Gea, and on behalf of the ENIGMA in COPD project
N-acetylcysteine increases manganese superoxide dismutase activity in septic rat diaphragms
Eur. Respir. J.,
December 1, 2005;
26(6):
1032 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Y. POLOTSKY, J. A. WILSON, A. S. HAINES, M. T. SCHARF, S. E. SOUTIERE, C. G. TANKERSLEY, P. L. SMITH, A. R. SCHWARTZ, and C. P. O'DONNELL
The Impact of Insulin-Dependent Diabetes on Ventilatory Control in the Mouse
Am. J. Respir. Crit. Care Med.,
March 1, 2001;
163(3):
624 - 632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Fahim, M. Y. Hasan, and W. B. Alshuaib
Early morphological remodeling of neuromuscular junction in a murine model of diabetes
J Appl Physiol,
December 1, 2000;
89(6):
2235 - 2240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. TRAVALINE, S. SUDARSHAN, B. G. ROY, F. CORDOVA, V. LEYENSON, and G. J. CRINER
Effect of N-Acetylcysteine on Human Diaphragm Strength and Fatigability
Am. J. Respir. Crit. Care Med.,
November 1, 1997;
156(5):
1567 - 1571.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|